Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure

Eplerenone in patients with systolic heart failure and mild symptoms

Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111 · see citing works

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.

Pfeffer, M. A., & D, E. B. M. (1990) · Circulation · doi:10.1161/01.cir.81.4.1161 · Cited by 2,873 · see citing works

Long-term trends in the incidence of and survival with heart failure

Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. L., Murabito, J. M., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020265 · Cited by 2,152 · see citing works

Ventricular Remodeling after Myocardial Infarction

Mitchell, G. F., Lamas, G. A., & Pfeffer, M. A. (1993) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2946-0_25 · Cited by 756 · see citing works

Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.

Pfeffer, M. A., Pfeffer, J. M., Steinberg, C., & Finn, P. V. (1985) · Circulation · doi:10.1161/01.cir.72.2.406 · Cited by 717 · see citing works

Heart Failure Incidence and Survival (from the Atherosclerosis Risk in Communities Study)

Loehr, L. R., Rosamond, W. D., Chang, P. P., Folsom, A. R., & Chambless, L. E. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.061 · Cited by 712 · see citing works

Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat.

Litwin, S. E., Katz, S. E., Morgan, J. P., & Douglas, P. S. (1994) · Circulation · doi:10.1161/01.cir.89.1.345 · Cited by 420 · see citing works

Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix

Kandasamy, A. D., Chow, A. K., Ali, M. A., & Schulz, R. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp268 · Cited by 289 · see citing works

An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive Hypertension

Imig, J. D., Zhao, X., Zaharis, C. Z., Olearczyk, J. J., Pollock, D. M., Newman, J. W. I., Kim, I.-H., Watanabe, T., & Hammock, B. D. (2005) · Hypertension · doi:10.1161/01.hyp.0000176237.74820.75 · Cited by 260 · see citing works

Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors

Xu, D., Li, N., He, Y., Timofeyev, V., Lü, L., Tsai, H.-J., Kim, I.-H., Tuteja, D., Mateo, R. K. P., Singapuri, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609158103 · Cited by 235 · see citing works

Measurement of circulating nitrite and S-nitrosothiols by reductive chemiluminescence

MacArthur, P. H., Shiva, S., & Gladwin, M. T. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.12.012 · Cited by 229 · see citing works

Orally Bioavailable Potent Soluble Epoxide Hydrolase Inhibitors

Hwang, S. H., Tsai, H.-J., Liu, J., Morisseau, C. H. P., & Hammock, B. D. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070270t · Cited by 225 · see citing works

Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease

Monti, J., Fischer, J., Paskaš, S., Heinig, M., Schulz, H., Gösele, C., Heuser, A., Fischer, R., Schmidt, C., Schirdewan, A., et al. (2008) · Nature Genetics · doi:10.1038/ng.129 · Cited by 176 · see citing works

Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia

Dhanasekaran, A., Gruenloh, S. K., Buonaccorsi, J. N., Zhang, R., Gross, G. J., Falck, J. R., Patel, P. K., Jacobs, E. R., & Medhora, M. M. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00979.2007 · Cited by 164 · see citing works

Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy

Ai, D., Pang, W., Li, N., Xu, M., Jones, P. D., Yang, J., Zhang, Y., Chiamvimonvat, N., Shyy, J. Y.-J., Hammock, B. D., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811022106 · Cited by 155 · see citing works

Epoxyeicosatrienoic acids, cell signaling and angiogenesis

Fleming, I. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.05.003 · Cited by 132 · see citing works

Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone

Mulder, P. G. H., Mellin, V., Favre, J., Vercauteren, M., Rémy‐Jouet, I., Monteil, C., Richard, V. J., Renet, S., Henry, J. P., Jeng, A. Y., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn277 · Cited by 126 · see citing works

Improvement in Left Ventricular Remodeling by the Endothelial Nitric Oxide Synthase Enhancer AVE9488 After Experimental Myocardial Infarction

Fraccarollo, D., Widder, J. D., Galuppo, P., Thum, T., Tsikas, D., Hoffmann, M., Ruetten, H., Ertl, G., & Bauersachs, J. K. (2008) · Circulation · doi:10.1161/circulationaha.107.717702 · Cited by 120 · see citing works

Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction

Liu, Y.-H., Carretero, O. A., Cingolani, O. H., Liao, T., Sun, Y., Xu, J., Li, L. Y., Pagano, P. J., Yang, J. J., & Yang, X.-P. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00546.2005 · Cited by 118 · see citing works

Vascular Cytochrome P450 Enzymes: Physiology and Pathophysiology

Fleming, I. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.11.002 · Cited by 103 · see citing works

High‐resolution myocardial perfusion mapping in small animals in vivo by spin‐labeling gradient‐echo imaging

Kober, F., Iltis, I., Izquierdo, M., Desrois, M., Ibarrola, D., Cozzone, P. J., & Bernard, M. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10676 · Cited by 95 · see citing works

Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure

Mellin, V., Isabelle, M., Oudot, A., Vergely, C., Monteil, C., Meglio, B. D., Henry, J., Dautréaux, B., Rochette, L., Thuillez, C., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi305 · Cited by 90 · see citing works

Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches

Li, N., Liu, J., Timofeyev, V., Qiu, H., Hwang, S. H., Tuteja, D., Lü, L., Yang, J., Mochida, H., Low, R., et al. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.08.017 · Cited by 87 · see citing works

Arteriogenic Therapy by Intramyocardial Sustained Delivery of a Novel Growth Factor Combination Prevents Chronic Heart Failure

Banquet, S., Gomez, É., Nicol, L., Edwards‐Lévy, F., Henry, J., Cao, R., Schapman, D., Dautréaux, B., Lallemand, F., Bauer, F., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.010264 · Cited by 84 · see citing works

Magnetization exchange in capillaries by microcirculation affects diffusion‐controlled spin‐relaxation: A model which describes the effect of perfusion on relaxation enhancement by intravascular contrast agents

Bauer, W. R., Hiller, K., Roder, F., Rommel, E., Ertl, G., & Haase, A. (1996) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910350107 · Cited by 79 · see citing works

Improvement of Peripheral Endothelial Dysfunction by Protein Tyrosine Phosphatase Inhibitors in Heart Failure

Vercauteren, M., Rémy, E., Devaux, C., Dautréaux, B., Henry, J., Bauer, F., Mulder, P. G. H., van Huijsduijnen, R. H., Bombrun, A., Thuillez, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.630129 · Cited by 72 · see citing works

Soluble Epoxide Hydrolase in Atherosclerosis

Wang, Y.-X. J., Ulu, A., Zhang, L.-N., & Hammock, B. D. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0108-5 · Cited by 70 · see citing works

Activation of Peroxisome Proliferator-Activated Receptor α by Substituted Urea-Derived Soluble Epoxide Hydrolase Inhibitors

Fang, X., Hu, S., Watanabe, T., Weintraub, N. L., Snyder, G. D., Yao, J., Liu, Y., Shyy, J. Y.-J., Hammock, B. D., & Spector, A. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085605 · Cited by 70 · see citing works

Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure

Saito, T., Hu, F., Tayara, L., Fahas, L., Shennib, H., & Giaid, A. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00596.2001 · Cited by 56 · see citing works

Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: A promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?

Bellien, J., Joannidès, R., Richard, V. J., & Thuillez, C. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.03.015 · Cited by 54 · see citing works

Epoxyeicosatrienoic Acids and/or Their Metabolites Promote Hypoxic Response of Cells

Suzuki, S., Oguro, A., Osada‐Oka, M., Funae, Y., & Imaoka, S. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08122fp · Cited by 47 · see citing works

Regulation of endothelial nitric-oxide synthase activity through phosphorylation in response to epoxyeicosatrienoic acids

Jiang, J. G., Chen, R. J., Xiao, B., Yang, S., Wang, J. N., Wang, Y., Cowart, L. A., Xiao, X., Wang, D. W., & Xia, Y. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.08.005 · Cited by 44 · see citing works

Improvement of left ventricular diastolic function induced by β-blockade

Fang, Y., Nicol, L., Harouki, N., Monteil, C., Wecker, D., Debunne, M., Bauer, F., Lallemand, F., Richard, V. J., Thuillez, C., et al. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.05.012 · Cited by 28 · see citing works

Soluble epoxide hydrolase inhibition prevents coronary endothelial dysfunction in mice with renovascular hypertension

Gao, J., Bellien, J., Gomez, É., Henry, J., Dautréaux, B., Bounoure, F., Skiba, M., Thuillez, C., & Richard, V. J. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328345ef7b · Cited by 25 · see citing works

Determination of epoxyeicosatrienoic acids in human red blood cells and plasma by GC/MS in the NICI mode

Goulitquer, S., Dréano, Y., Berthou, F., Corcos, L., & Lucas, D. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.10.035 · Cited by 23 · see citing works

Inhibition of the Adenosine 2A Receptor-Epoxyeicosatrienoic Acid Pathway Renders Dahl Salt-Resistant Rats Hypertensive

Liclican, E. L., Doumad, A. B., Wang, J., Li, J., Falck, J. R., Stier, C. T., & Carroll, M. A. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.123570 · Cited by 19 · see citing works

Reduced cardiac remodelling and prevention of glutathione deficiency after omega‐3 supplementation in chronic heart failure

Fang, Y., Favre, J., Vercauteren, M., Laillet, B., Rémy‐Jouet, I., Skiba, M., Lallemand, F., Dehaudt, C., Monteil, C., Thuillez, C., et al. (2010) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00839.x · Cited by 17 · see citing works

[Effect of 11, 12-epoxyeicosatrienoic acid on nitric oxide synthase of ischemia-reperfusion myocardium in rats].

Yan, L., Lu, L., Wang, H., Zeng, X., & Zhang, L.-K. (2005) · PubMed · Cited by 2 · see citing works

Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging

Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638 · see citing works

Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets

Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Zheng, W., Hu, J., Fleming, I., & Wang, D. W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00443-w · Cited by 1,467 · see citing works

Oxidative Stress in Cardiovascular Diseases

Dubois‐Deruy, E., Peugnet, V., Turkieh, A., & Pinet, F. (2020) · Antioxidants · doi:10.3390/antiox9090864 · Cited by 667 · see citing works

Soluble epoxide hydrolase: Gene structure, expression and deletion

Harris, T. R., & Hammock, B. D. (2013) · Gene · doi:10.1016/j.gene.2013.05.008 · Cited by 235 · see citing works

Cytochrome P450-derived eicosanoids and heart function

Jamieson, K. L., Endo, T. H., Darwesh, A. M., Samokhvalov, V., & Seubert, J. M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.005 · Cited by 119 · see citing works

Epoxyeicosatrienoic Acid Pathway in Human Health and Diseases

Bellien, J., & Joannidés, R. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318273b007 · Cited by 92 · see citing works

Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics

Imig, J. D. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.015 · Cited by 89 · see citing works

Inside epoxyeicosatrienoic acids and cardiovascular disease

Tacconelli, S., & Patrignani, P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00239 · Cited by 70 · see citing works

Epoxyeicosatrienoic acids and cardioprotection: The road to translation

Oni‐Orisan, A., Alsaleh, N. B., Lee, C. R., & Seubert, J. M. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.05.016 · Cited by 65 · see citing works

EET intervention on Wnt1, NOV, and HO-1 signaling prevents obesity-induced cardiomyopathy in obese mice

Cao, J. J., Singh, S. P., McClung, J. A., Joseph, G. U., Vanella, L., Barbagallo, I. A., Jiang, H., Falck, J. R., Arad, M., Shapiro, J. I., et al. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00093.2017 · Cited by 65 · see citing works

CYP2J2 overexpression increases EETs and protects against angiotensin II-induced abdominal aortic aneurysm in mice

Cai, Z., Zhao, G., Yan, J., Liu, W., Feng, W., Ma, B., Yang, L., Wang, J.-A., Tu, L., & Wang, D. W. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m036533 · Cited by 62 · see citing works

The Role of Epoxyeicosatrienoic Acids in Cardiac Remodeling

Lai, J.-S., & Chen, C. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.642470 · Cited by 53 · see citing works

Soluble Epoxide Hydrolase

Gupta, N. C., Davis, C. M., Nelson, J. W., Young, J. M., & Alkayed, N. J. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.251520 · Cited by 59 · see citing works

Regulation of miRNAs by Natural Antioxidants in Cardiovascular Diseases: Focus on SIRT1 and eNOS

Lee, Y., & Im, E. (2021) · Antioxidants · doi:10.3390/antiox10030377 · Cited by 59 · see citing works

Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B‐deficient mice

Besnier, M., Galaup, A., Nicol, L., Henry, J., Coquerel, D., Gueret, A., Mulder, P. G. H., Bråkenhielm, E., Thuillez, C., Germain, S., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-245753 · Cited by 56 · see citing works

Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice

Roche, C., Besnier, M., Cassel, R., Harouki, N., Coquerel, D., Guerrot, D., Nicol, L., Loizon, E., Rémy‐Jouet, I., Morisseau, C. H. P., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00465.2014 · Cited by 56 · see citing works

Myocardial arterial spin labeling

Kober, F., Jao, T. R., Troalen, T., & Nayak, K. S. (2016) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-016-0235-4 · Cited by 53 · see citing works

In vitro aged, hiPSC-origin engineered heart tissue models with age-dependent functional deterioration to study myocardial infarction

Acun, A., Nguyen, T. D., & Zorlutuna, P. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.064 · Cited by 50 · see citing works

Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria

Guo, Z., Sevrioukova, I. F., Denisov, I. G., Zhang, X., Chiu, T.-L., Thomas, D. G., Hanse, E. A., Cuellar, R. A. D., Grinkova, Y. V., Langenfeld, V. W., et al. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.08.009 · Cited by 51 · see citing works

Epoxyeicosatrienoic Acid as Therapy for Diabetic and Ischemic Cardiomyopathy

Romashko, M. D., Schragenheim, J., Abraham, N. G., & McClung, J. A. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.08.001 · Cited by 50 · see citing works

Heart failure–induced activation of phospholipase iPLA2γ generates hydroxyeicosatetraenoic acids opening the mitochondrial permeability transition pore

Moon, S. H., Liu, X., Cedars, A. M., Yang, K., Kiebish, M. A., Joseph, S. M., Kelley, J., Jenkins, C. M., & Gross, R. W. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000405 · Cited by 49 · see citing works

Mitochondrial Dysfunction and Inflammaging in Heart Failure: Novel Roles of CYP-Derived Epoxylipids

Keshavarz-Bahaghighat, H., Darwesh, A. M., Sosnowski, D. K., & Seubert, J. M. (2020) · Cells · doi:10.3390/cells9071565 · Cited by 49 · see citing works

Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications

McClung, J. A., Levy, L., Garcia, V. G., Stec, D. E., Peterson, S. J., & Abraham, N. G. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107975 · Cited by 47 · see citing works

Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases

Duflot, T., Roche, C., Lamoureux, F., Guerrot, D., & Bellien, J. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.881354 · Cited by 42 · see citing works

CYP epoxygenase 2J2 prevents cardiac fibrosis by suppression of transmission of pro-inflammation from cardiomyocytes to macrophages

Yang, L., Ni, L., Duan, Q., Wang, X., Chen, C., Chen, S., Chaugai, S., Zeldin, D. C., Tang, J. R., & Wang, D. W. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.01.004 · Cited by 39 · see citing works

Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway

Liang, Y., Jing, Z., Deng, H., Li, Z., Zhuang, Z., Wang, S., & Wang, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.05.020 · Cited by 39 · see citing works

Proteomic Analysis of Hearts from Akita Mice Suggests That Increases in Soluble Epoxide Hydrolase and Antioxidative Programming Are Key Changes in Early Stages of Diabetic Cardiomyopathy

Dewey, S., Lai, X., Witzmann, F. A., Sohal, M., & Gomes, A. V. (2013) · Journal of Proteome Research · doi:10.1021/pr4004739 · Cited by 35 · see citing works

Inhibition of Soluble Epoxide Hydrolase Limits Mitochondrial Damage and Preserves Function Following Ischemic Injury

Akhnokh, M. K., Yang, F. H., Samokhvalov, V., Jamieson, K. L., Cho, W. J., Wagg, C. S., Takawale, A. R., Wang, X., Lopaschuk, G. D., Hammock, B. D., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00133 · Cited by 35 · see citing works

Effect of inflammation on cytochrome P450-mediated arachidonic acid metabolism and the consequences on cardiac hypertrophy

Elkhatib, M. A. W., Isse, F. A., & El‐Kadi, A. O. S. (2022) · Drug Metabolism Reviews · doi:10.1080/03602532.2022.2162075 · Cited by 33 · see citing works

Inhibition of Soluble Epoxide Hydrolase Does Not Improve the Course of Congestive Heart Failure and the Development of Renal Dysfunction in Rats With Volume Overload Induced by Aorto-Caval Fistula

Červenka, L., Melenovský, V., Husková, Z., Sporková, A., Bürgelová, M., Škaroupková, P., HWANG, S. H., Hammock, B. D., Imig, J. D., & Sadowski, J. (2015) · Physiological Research · doi:10.33549/physiolres.932977 · Cited by 31 · see citing works

Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice

Roche, C., Guerrot, D., Harouki, N., Duflot, T., Besnier, M., Rémy‐Jouet, I., Renet, S., Dumesnil, A., Lejeune, A., Morisseau, C. H. P., et al. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.04.011 · Cited by 29 · see citing works

Epoxyeicosatrienoic acids mediate insulin-mediated augmentation in skeletal muscle perfusion and blood volume

Shim, C. Y., Kim, S., Chadderdon, S. M., Wu, M. D., Qi, Y., Xie, A., Alkayed, N. J., Davidson, B. P., & Lindner, J. R. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00216.2014 · Cited by 28 · see citing works

Mitochondrial-Targeted Therapies Require Mitophagy to Prevent Oxidative Stress Induced by SOD2 Inactivation in Hypertrophied Cardiomyocytes

Peugnet, V., Chwastyniak, M., Mulder, P. G. H., Lancel, S., Bultot, L., Fourny, N., Renguet, E., Bugger, H., Beseme, O., Loyens, A., et al. (2022) · Antioxidants · doi:10.3390/antiox11040723 · Cited by 26 · see citing works

Genetic deletion of soluble epoxide hydrolase provides cardioprotective responses following myocardial infarction in aged mice

Jamieson, K. L., Samokhvalov, V., Akhnokh, M. K., Lee, K., Cho, W. J., Takawale, A. R., Wang, X., Kassiri, Z., & Seubert, J. M. (2017) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2017.01.001 · Cited by 26 · see citing works

Epoxyeicosatrienoic acid analog EET-B attenuates post-myocardial infarction remodeling in spontaneously hypertensive rats

Neckář, J., Khan, A. H., Gross, G. J., Cyprová, M., Hrdlička, J., Kvasilová, A., Falck, J. R., Campbell, W. B., Sedláková, L., Škutová, Š., et al. (2019) · Clinical Science · doi:10.1042/cs20180728 · Cited by 26 · see citing works

Soluble Epoxide Hydrolase Inhibition Does Not Prevent Cardiac Remodeling and Dysfunction After Aortic Constriction in Rats and Mice

Morgan, L. A., Olzinski, A. R., Upson, J. J., Zhao, S., Wang, T., Eisennagel, S., Hoang, B. Q., Tunstead, J. R., Marino, J. P., Willette, R. N., et al. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31827fe59c · Cited by 25 · see citing works

The apoptosis-resistance in t-AUCB-treated glioblastoma cells depends on activation of Hsp27

Li, J., Hu, W., & Lan, Q. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0963-8 · Cited by 25 · see citing works

CYP2J2 Overexpression Increases EETs and Protects Against HFD-Induced Atherosclerosis in ApoE−/− Mice

Liu, W., Wang, T., He, X., Liu, X., Wang, B., Liu, Y., Li, Z., Tan, R., Ding, C., Wang, H., et al. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000371 · Cited by 25 · see citing works

Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis

Vanella, L., Canestraro, M., Lee, C. R., Cao, J. J., Zeldin, D. C., Schwartzman, M. L., & Abraham, N. G. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.04.004 · Cited by 22 · see citing works

Increased Soluble Epoxide Hydrolase Activity Positively Correlates with Mortality in Heart Failure Patients with Preserved Ejection Fraction: Evidence from Metabolomics

Peng, L., Song, Z., Zhao, C., Abuduwufuer, K., Wang, Y., Zheng, W., Ni, L., Li, C., Yu, Y., Zhu, Y., et al. (2022) · Phenomics · doi:10.1007/s43657-022-00069-8 · Cited by 21 · see citing works

Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive Ren-2 Transgenic Rats

Hrdlička, J., Neckář, J., Papoušek, F., Husková, Z., Kikerlová, S., Vaňourková, Z., Vernerová, Z., Akat, F., Vašinová, J., Hammock, B. D., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00159 · Cited by 19 · see citing works

Nox4 and soluble epoxide hydrolase synergistically mediate homocysteine-induced inflammation in vascular smooth muscle cells

Liu, X., Qin, Z., Liu, C., Song, M., Luo, X., Zhao, H., Qian, D., Chen, J., & Huang, L. J. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2019.01.001 · Cited by 18 · see citing works

Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs

Zhang, Y., Gao, L., Yao, B., Huang, S., Zhang, Y., Liu, J., Liu, Z., & Wang, X. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121122 · Cited by 17 · see citing works

Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors

Takai, K., Chiyo, N., Nakajima, T., Nariai, T., Ishikawa, C., Nakatani, S., Ikeno, A., Yamamoto, S., & Sone, T. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.02.076 · Cited by 17 · see citing works

Protective effect of fenofibrate against ischemia‐/reperfusion‐induced cardiac arrhythmias in isolated rat hearts

Bukhari, I. A., Almotrefi, A. A., Mohamed, O., Al‐Masri, A. A., & Sheikh, S. A. (2017) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12342 · Cited by 18 · see citing works

Assessment of endothelial damage and cardiac injury in a mouse model mimicking thrombotic thrombocytopenic purpura

le Besnerais, M., Favre, J., Denis, C. V., Mulder, P. G. H., Martinet, J., Nicol, L., Levesque, H., Veyradier, A., Kopić, A., Motto, D. G., et al. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13439 · Cited by 14 · see citing works

CYP2J2-mediated metabolism of arachidonic acid in heart: A review of its kinetics, inhibition and role in heart rhythm control.

Leow, J. W. H., & Chan, E. C. Y. (2024) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2024.108637 · Cited by 12 · see citing works

Mechanisms of epoxyeicosatrienoic acids to improve cardiac remodeling in chronic renal failure disease

Zhang, K., Wang, J., Zhang, H., Chen, J., Zuo, Z., Wang, J., & Huang, H. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.12.025 · Cited by 11 · see citing works

Subtotal Nephrectomy Associated with a High-Phosphate Diet in Rats Mimics the Development of Calcified Aortic Valve Disease Associated with Chronic Renal Failure

Messaoudi, H., Lévesque, T., Perzo, N., Berg, E., Feugray, G., Dumesnil, A., Brunel, V., Guerrot, D., Eltchaninoff, H., Richard, V. J., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041539 · Cited by 9 · see citing works

Soluble Epoxide Hydrolase Inhibition Prevents Experimental Type 4 Cardiorenal Syndrome

Hamzaoui, M., Roche, C., Coquerel, D., Duflot, T., Brunel, V., Mulder, P. G. H., Richard, V. J., Bellien, J., & Guerrot, D. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.604042 · Cited by 9 · see citing works

The role of CYP-sEH derived lipid mediators in regulating mitochondrial biology and cellular senescence: implications for the aging heart

Yousef, A., Fang, L., Heidari, M., Kranrod, J. W., & Seubert, J. M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1486717 · Cited by 7 · see citing works

Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?

Duflot, T., Tu, L., Leuillier, M., Messaoudi, H., Groussard, D., Feugray, G., Azhar, S., Thuillet, R., Bauer, F., Humbert, M. J. C., et al. (2021) · Metabolites · doi:10.3390/metabo11110784 · Cited by 6 · see citing works

EETs mediate cardioprotection of salvianolic acids through MAPK signaling pathway

Wang, S., Zhang, W., Pang, X., Li, L., He, G., Yang, X., Fang, L., Zhang, J., & Du, G. (2013) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.12.006 · Cited by 5 · see citing works

Conséquences cardiovasculaires de l’insuffisance rénale chronique, intérêt d’une modulation des acides époxyeicosatriénoïques

Hamzaoui, M., Guerrot, D., Djerada, Z., Duflot, T., Richard, V. J., & Bellien, J. (2018) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2018.04.018 · Cited by 3 · see citing works

Recent Developments in Small Animal Cardiovascular MRI

Kober, F., Troalen, T., & Bernard, M. (2014) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-013-9249-6 · Cited by 2 · see citing works

Identification of arachidonic acid metabolism-related diagnostic markers in heart failure based on bioinformatics analysis and machine learning

Chen, S., Zhang, C., & Yu, Y. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1625064 · Cited by 1 · see citing works

TRANSLATIONAL APPROACHES TO UNDERSTANDING THE ROLE OF CYTOCHROME P450-DERIVED EPOXYEICOSATRIENOIC ACIDS IN CORONARY ARTERY DISEASE

Oni‐Orisan, A. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/w552-8s55

Restore mitophagy is essential to prevent cardiac oxidative stress during hypertrophyPreprint

Peugnet, V., Chwastyniak, M., Lancel, S., Bultot, L., Fourny, N., Beseme, O., Loyens, A., Heyse, W., Amouyel, P., Bertrand, L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.12.426366

The apoptosis-resistance in t-AUCB-treated glioblastoma cells depends on activation of Hsp27

LiWeixing, J., & Lan, H. (2012)

Cardioprotective Effects of Soluble Epoxide Hydrolase Inhibition Following Myocardial Infarction

Jamieson, K. L. (2020) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-ha5a-nh95

Current World Literature

(2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328360f5be

Adjusted analysis

Lee, P. H. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.05.011

Perfusion MRI in the heart: Arterial spin labeling

Aramendía‐Vidaurreta, V., & Kober, F. (2023) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-323-95209-5.00008-8

BindingDB Entry 50045531: Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors.

BindingDB (2016) · UC San Diego · doi:10.7270/q25h7hx9

Effects of pharmacological inhibition of the hydrolase activity of soluble epoxide hydrolase in a murine model of pulmonary hypertension associated with cardiac insufficiency

Leuillier, M., Groussard, D., Lachaux, M., Hamzaoui, M., Henry, J., Nicol, L., Dumesnil, A., Mulder, P. G. H., Richard, V. J., & Bellien, J. (2019) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/j.acvdsp.2019.02.044

Effects of pharmacological inhibition of the hydrolase activity of soluble epoxide hydrolase in a murine model of pulmonary hypertension associated or not with cardiac insufficiency

Leuillier, M., Groussard, D., Lachaux, M., Hamzaoui, M., Henry, J., Nicol, L., Dumesnil, A., Mulder, P. G. H., Richard, V. J., & Bellien, J. (2018) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/j.acvdsp.2018.02.074

Soluble Epoxide Hydrolase Inhibitors and Heart Failure

Qiu, H., Li, N., Liu, J., Harris, T. R., Hammock, B. D., & Chiamvimonvat, N. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00150.x · Cited by 73 · see citing works

Inhibition of soluble epoxide hydrolase increases coronary perfusion in mice

Qin, J., Sun, D., Jiang, H., Kandhi, S., Froogh, G., Hwang, S. H., Hammock, B. D., Wolin, M. S., Thompson, C. I., Hintze, T. H., et al. (2015) · Physiological Reports · doi:10.14814/phy2.12427 · Cited by 15 · see citing works

Inhibition of Soluble Epoxide Hydrolase Increases Coronary Flow and Improves Cardiac Work in Mice

Qin, J., Jiang, H., Kandhi, S., Froogh, G., Thompson, C., Huang, A., & Sun, D. (2015) · The FASEB Journal · doi:10.1096/fasebj.29.1_supplement.644.9